| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ribonucleoprotein complex binding | 3.50e-05 | 206 | 120 | 8 | GO:0043021 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of cell polarity | 2.27e-06 | 257 | 118 | 10 | GO:0007163 | |
| GeneOntologyBiologicalProcess | establishment of cell polarity | 8.23e-06 | 177 | 118 | 8 | GO:0030010 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to insulin stimulus | 2.51e-05 | 101 | 118 | 6 | GO:1900076 | |
| GeneOntologyBiologicalProcess | regulation of cellular component size | MYH9 WNT7A ARFGEF1 PUM2 NEB TTC3 NEFL PAK1 PRKCD STK39 GOLGA4 | 3.38e-05 | 426 | 118 | 11 | GO:0032535 |
| GeneOntologyBiologicalProcess | establishment of organelle localization | SEC16B MYH9 MYO5A CENPF APC FYCO1 TACC2 FNBP1L NEFL INSC EXOC6B KNL1 | 7.01e-05 | 546 | 118 | 12 | GO:0051656 |
| GeneOntologyBiologicalProcess | positive regulation of plasma membrane bounded cell projection assembly | 7.60e-05 | 123 | 118 | 6 | GO:0120034 | |
| GeneOntologyBiologicalProcess | formation of cytoplasmic translation initiation complex | 7.90e-05 | 15 | 118 | 3 | GO:0001732 | |
| GeneOntologyBiologicalProcess | establishment of T cell polarity | 7.90e-05 | 15 | 118 | 3 | GO:0001768 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection assembly | 9.15e-05 | 248 | 118 | 8 | GO:0120032 | |
| GeneOntologyBiologicalProcess | establishment of lymphocyte polarity | 9.68e-05 | 16 | 118 | 3 | GO:0001767 | |
| GeneOntologyBiologicalProcess | regulation of cell projection assembly | 9.94e-05 | 251 | 118 | 8 | GO:0060491 | |
| GeneOntologyBiologicalProcess | microtubule-based process | FLOT2 MYH9 RIPOR2 MYO5A CKAP5 APC FYCO1 TACC2 DNAH7 PRUNE1 CCDC88C NEFL DNAH12 INSC PAK1 DNAI4 CFAP46 | 1.08e-04 | 1058 | 118 | 17 | GO:0007017 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | RPGRIP1 TBC1D15 EPS8L2 RIPOR2 FBF1 APC FNBP1L DNAH7 DNAI4 PRKCD PRKCQ CFAP46 PLCE1 | 1.21e-04 | 670 | 118 | 13 | GO:0120031 |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | MYH9 RIPOR2 CKAP5 APC ARFGEF1 NEB PRUNE1 CCDC88C TJP1 PAK1 PRKCD PRKCQ | 1.22e-04 | 579 | 118 | 12 | GO:0051493 |
| GeneOntologyBiologicalProcess | cell projection assembly | RPGRIP1 TBC1D15 EPS8L2 RIPOR2 FBF1 APC FNBP1L DNAH7 DNAI4 PRKCD PRKCQ CFAP46 PLCE1 | 1.51e-04 | 685 | 118 | 13 | GO:0030031 |
| GeneOntologyBiologicalProcess | cell division | PDS5B MYH9 CENPF WNT7A ANXA11 CKAP5 APC BLM LIG1 INSC EXOC6B RAB11FIP4 KNL1 | 1.79e-04 | 697 | 118 | 13 | GO:0051301 |
| GeneOntologyBiologicalProcess | regulation of insulin receptor signaling pathway | 1.86e-04 | 92 | 118 | 5 | GO:0046626 | |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | 2.13e-04 | 438 | 118 | 10 | GO:1902903 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | TBC1D15 MYH9 RIPOR2 MYO5A CENPF CKAP5 APC ARFGEF1 CCT2 FYCO1 NEB PRUNE1 CCDC88C CNOT6L TJP1 PAK1 PRKCD PRKCQ KNL1 | 2.15e-04 | 1342 | 118 | 19 | GO:0033043 |
| GeneOntologyBiologicalProcess | regulation of alpha-beta T cell proliferation | 2.40e-04 | 53 | 118 | 4 | GO:0046640 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | MYH9 RIPOR2 CKAP5 APC TACC2 DNAH7 PRUNE1 CCDC88C NEFL INSC PAK1 DNAI4 CFAP46 | 2.46e-04 | 720 | 118 | 13 | GO:0000226 |
| GeneOntologyBiologicalProcess | negative regulation of insulin receptor signaling pathway | 2.58e-04 | 54 | 118 | 4 | GO:0046627 | |
| GeneOntologyBiologicalProcess | insulin receptor signaling pathway | 2.79e-04 | 156 | 118 | 6 | GO:0008286 | |
| GeneOntologyBiologicalProcess | regulation of filopodium assembly | 3.18e-04 | 57 | 118 | 4 | GO:0051489 | |
| GeneOntologyBiologicalProcess | response to camptothecin | 3.21e-04 | 5 | 118 | 2 | GO:1901563 | |
| GeneOntologyBiologicalProcess | regulation of mRNA binding | 3.21e-04 | 5 | 118 | 2 | GO:1902415 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA binding | 3.21e-04 | 5 | 118 | 2 | GO:1902416 | |
| GeneOntologyBiologicalProcess | cellular response to camptothecin | 3.21e-04 | 5 | 118 | 2 | GO:0072757 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | TBC1D15 EPS8L2 RIPOR2 WNT7A APC PUM2 FNBP1L TTC3 NEFL PAK1 PRKCD PRKCQ GOLGA4 PLCE1 | 3.42e-04 | 846 | 118 | 14 | GO:0120035 |
| GeneOntologyBiologicalProcess | alpha-beta T cell proliferation | 3.63e-04 | 59 | 118 | 4 | GO:0046633 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular response to insulin stimulus | 3.63e-04 | 59 | 118 | 4 | GO:1900077 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | MYH9 MYO5A CAPN3 CKAP5 APC ARFGEF1 TACC2 NEB PRUNE1 CCDC88C NEFL TJP1 PAK1 PRKCD PRKCQ | 3.70e-04 | 957 | 118 | 15 | GO:0097435 |
| GeneOntologyBiologicalProcess | regulation of protein polymerization | 3.71e-04 | 231 | 118 | 7 | GO:0032271 | |
| GeneOntologyBiologicalProcess | regulation of establishment of cell polarity | 3.83e-04 | 25 | 118 | 3 | GO:2000114 | |
| GeneOntologyBiologicalProcess | regulation of microtubule polymerization or depolymerization | 3.92e-04 | 108 | 118 | 5 | GO:0031110 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | TBC1D15 EPS8L2 RIPOR2 WNT7A APC PUM2 FNBP1L TTC3 NEFL PAK1 PRKCD PRKCQ GOLGA4 PLCE1 | 4.17e-04 | 863 | 118 | 14 | GO:0031344 |
| GeneOntologyBiologicalProcess | positive regulation of RNA binding | 4.80e-04 | 6 | 118 | 2 | GO:1905216 | |
| GeneOntologyBiologicalProcess | regulation of axon diameter | 4.80e-04 | 6 | 118 | 2 | GO:0031133 | |
| GeneOntologyBiologicalProcess | regulation of establishment of T cell polarity | 4.80e-04 | 6 | 118 | 2 | GO:1903903 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | MYH9 EPS8L2 RIPOR2 WNT7A CKAP5 APC FNBP1L CNOT6L PAK1 PRKCQ PLCE1 | 5.15e-04 | 582 | 118 | 11 | GO:0044089 |
| GeneOntologyBiologicalProcess | cell cycle process | PDS5B MYH9 RIPOR2 CENPF ANXA11 CAPN3 CKAP5 SLFN12 APC PUM2 TACC2 BLM LIG1 INSC RAD54B EXOC6B PRKCQ RAB11FIP4 KNL1 | 5.23e-04 | 1441 | 118 | 19 | GO:0022402 |
| GeneOntologyBiologicalProcess | regulation of microtubule cytoskeleton organization | 5.30e-04 | 176 | 118 | 6 | GO:0070507 | |
| GeneOntologyBiologicalProcess | regulation of CD4-positive, alpha-beta T cell proliferation | 5.39e-04 | 28 | 118 | 3 | GO:2000561 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | 5.49e-04 | 494 | 118 | 10 | GO:0031346 | |
| GeneOntologyBiologicalProcess | regulation of microtubule polymerization | 6.61e-04 | 69 | 118 | 4 | GO:0031113 | |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell proliferation | 6.62e-04 | 30 | 118 | 3 | GO:0035739 | |
| GeneOntologyBiologicalProcess | regulation of establishment or maintenance of cell polarity | 6.62e-04 | 30 | 118 | 3 | GO:0032878 | |
| GeneOntologyBiologicalProcess | protein polymerization | 6.80e-04 | 334 | 118 | 8 | GO:0051258 | |
| GeneOntologyBiologicalProcess | T cell activation | FLOT2 MYH9 RIPOR2 ITCH SLFN12 APC CASP8 AZI2 BLM PTPN2 CARD11 PRKCQ | 6.88e-04 | 701 | 118 | 12 | GO:0042110 |
| GeneOntologyBiologicalProcess | organelle localization | SEC16B MYH9 MYO5A CENPF APC FYCO1 TACC2 FNBP1L NEFL INSC EXOC6B KNL1 | 7.06e-04 | 703 | 118 | 12 | GO:0051640 |
| GeneOntologyBiologicalProcess | positive regulation of alpha-beta T cell proliferation | 7.30e-04 | 31 | 118 | 3 | GO:0046641 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | MYH9 WNT7A ARFGEF1 PUM2 NEB TTC3 NEFL PAK1 PRKCD STK39 GOLGA4 | 8.44e-04 | 618 | 118 | 11 | GO:0090066 |
| GeneOntologyBiologicalProcess | negative regulation of cytoskeleton organization | 8.83e-04 | 194 | 118 | 6 | GO:0051494 | |
| GeneOntologyBiologicalProcess | regulation of RNA binding | 8.88e-04 | 8 | 118 | 2 | GO:1905214 | |
| GeneOntologyBiologicalProcess | positive regulation of microtubule nucleation | 8.88e-04 | 8 | 118 | 2 | GO:0090063 | |
| GeneOntologyBiologicalProcess | replication-born double-strand break repair via sister chromatid exchange | 8.88e-04 | 8 | 118 | 2 | GO:1990414 | |
| GeneOntologyBiologicalProcess | cellular response to insulin stimulus | 9.55e-04 | 271 | 118 | 7 | GO:0032869 | |
| GeneOntologyBiologicalProcess | negative regulation of supramolecular fiber organization | 9.56e-04 | 197 | 118 | 6 | GO:1902904 | |
| GeneOntologyCellularComponent | eukaryotic translation initiation factor 3 complex, eIF3m | 1.51e-05 | 9 | 120 | 3 | GO:0071541 | |
| GeneOntologyCellularComponent | cytoplasmic region | RPGRIP1 FLOT2 CENPF CKAP5 DNAH7 NEFL DNAH12 INSC DNAI4 CFAP46 | 4.39e-05 | 360 | 120 | 10 | GO:0099568 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 9.07e-05 | 317 | 120 | 9 | GO:0032838 | |
| GeneOntologyCellularComponent | eukaryotic translation initiation factor 3 complex | 9.78e-05 | 16 | 120 | 3 | GO:0005852 | |
| GeneOntologyCellularComponent | eukaryotic 48S preinitiation complex | 1.41e-04 | 18 | 120 | 3 | GO:0033290 | |
| GeneOntologyCellularComponent | eukaryotic 43S preinitiation complex | 1.67e-04 | 19 | 120 | 3 | GO:0016282 | |
| GeneOntologyCellularComponent | translation preinitiation complex | 1.96e-04 | 20 | 120 | 3 | GO:0070993 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 3.87e-04 | 25 | 120 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | ITCH CENPF PRAMEF19 FBF1 APC CCT2 MIB2 PGGT1B POLR3F GTF2E1 AHRR DCUN1D1 CNOT6L RNF20 CARD11 | 4.54e-04 | 972 | 120 | 15 | GO:0140535 |
| GeneOntologyCellularComponent | intercellular canaliculus | 1.15e-03 | 9 | 120 | 2 | GO:0046581 | |
| GeneOntologyCellularComponent | axoneme | 1.26e-03 | 207 | 120 | 6 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 1.29e-03 | 208 | 120 | 6 | GO:0097014 | |
| GeneOntologyCellularComponent | cell cortex | 1.37e-03 | 371 | 120 | 8 | GO:0005938 | |
| GeneOntologyCellularComponent | ciliary transition fiber | 1.43e-03 | 10 | 120 | 2 | GO:0097539 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.43e-03 | 10 | 120 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | lamellipodium | 2.14e-03 | 230 | 120 | 6 | GO:0030027 | |
| Domain | EIF3C_N_dom | 3.82e-05 | 2 | 116 | 2 | IPR008905 | |
| Domain | eIF-3c_N | 3.82e-05 | 2 | 116 | 2 | PF05470 | |
| Domain | EIF3C | 3.82e-05 | 2 | 116 | 2 | IPR027516 | |
| Domain | - | 7.42e-05 | 222 | 116 | 8 | 1.25.10.10 | |
| Domain | Prot_kin_PKC_delta | 2.28e-04 | 4 | 116 | 2 | IPR014376 | |
| Domain | C2 | 2.60e-04 | 142 | 116 | 6 | PS50004 | |
| Domain | ARM-type_fold | 2.67e-04 | 339 | 116 | 9 | IPR016024 | |
| Domain | ARM-like | 2.84e-04 | 270 | 116 | 8 | IPR011989 | |
| Domain | - | 3.24e-04 | 148 | 116 | 6 | 2.60.40.150 | |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS | 4.14e-06 | 37 | 93 | 5 | MM14488 | |
| Pathway | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS | 4.74e-06 | 38 | 93 | 5 | M495 | |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 1.70e-05 | 49 | 93 | 5 | MM15448 | |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 2.28e-05 | 52 | 93 | 5 | M2341 | |
| Pathway | REACTOME_PROGRAMMED_CELL_DEATH | 4.18e-05 | 142 | 93 | 7 | MM15178 | |
| Pubmed | PDS5B AARS1 MYH9 MYO5A CENPF ANXA11 CKAP5 NSD1 CCT2 ITPR3 BLM NEFL IGF2BP2 TJP1 EIF3D | 9.34e-09 | 653 | 121 | 15 | 22586326 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | FLOT2 AARS1 MYH9 CKAP5 ANKRD26 PUM2 CCT2 TACC2 ADAR PRUNE1 GTF2E1 IGF2BP2 TJP1 EIF3C EIF3D GOLGB1 KNL1 | 2.75e-08 | 934 | 121 | 17 | 33916271 |
| Pubmed | DMXL2 MYH9 ITCH MYO5A CENPF CKAP5 NSD1 APC FYCO1 TTC3 ITIH1 CCDC88C NEFL TJP1 PAK1 GOLGA4 GOLGB1 | 4.28e-08 | 963 | 121 | 17 | 28671696 | |
| Pubmed | FLOT2 MYH9 ITCH PPFIBP1 APC ITPR3 TJP1 RNF20 STK39 GOLGA4 GOLGB1 | 5.81e-08 | 360 | 121 | 11 | 33111431 | |
| Pubmed | TBC1D15 MYH9 CENPF APC TACC2 ADAR EIF3CL BLM LIG1 PAK1 STK39 EIF3C | 2.07e-07 | 503 | 121 | 12 | 16964243 | |
| Pubmed | FLOT2 DMXL2 TBC1D15 ITCH PPFIBP1 ARFGEF1 FYCO1 ITPR3 VAC14 EIF3C GOLGA4 GOLGB1 | 2.11e-07 | 504 | 121 | 12 | 34432599 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 3.04e-07 | 256 | 121 | 9 | 33397691 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | PDS5B FLOT2 TBC1D15 MYO5A CENPF ANXA11 CKAP5 CCT2 ADAR ITPR3 NEFL IGF2BP2 TJP1 EIF3C EIF3D GOLGB1 | 5.64e-07 | 1024 | 121 | 16 | 24711643 |
| Pubmed | PDS5B RPGRIP1 MYH4 MYH9 MYO5A CENPF FBF1 ANKRD26 CCT2 FNBP1L NEB TTC3 NEFL TJP1 FAM186A ABCC2 HSPA6 GOLGB1 CFAP46 | 5.98e-07 | 1442 | 121 | 19 | 35575683 | |
| Pubmed | 8.15e-07 | 6 | 121 | 3 | 22528498 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | AARS1 MYH9 ITCH ANXA11 CKAP5 ARFGEF1 CCT2 FNBP1L ADAR PTPN2 IGF2BP2 TJP1 PAK1 STK39 EIF3C EIF3D GOLGB1 KNL1 | 1.24e-06 | 1367 | 121 | 18 | 32687490 |
| Pubmed | 1.40e-06 | 24 | 121 | 4 | 10843712 | ||
| Pubmed | 1.42e-06 | 7 | 121 | 3 | 35859177 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MYO5A CKAP5 ANKRD26 APC PUM2 FNBP1L TTC3 ADAR IGF2BP2 TJP1 SECISBP2 EIF3D WDR48 | 1.55e-06 | 724 | 121 | 13 | 36232890 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | FLOT2 AARS1 ITCH ARHGEF28 PPFIBP1 CKAP5 ANKRD26 APC DNAH7 CCDC88C TJP1 AASS GOLGA4 GOLGB1 | 1.91e-06 | 861 | 121 | 14 | 36931259 |
| Pubmed | AARS1 DMXL2 ITCH MYO5A PPFIBP1 CKAP5 APC CCT2 TTC3 FOCAD NEFL TJP1 PAK1 EIF3C EIF3D RAB11FIP4 RECK | 2.36e-06 | 1285 | 121 | 17 | 35914814 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | PDS5B SEC16B ARID4A CKAP5 TATDN2 PUM2 EIF3CL BLM LIG1 RNF20 PRKCD EIF3C GOLGA4 | 3.21e-06 | 774 | 121 | 13 | 15302935 |
| Pubmed | MYH9 PPFIBP1 ANKRD26 APC ARFGEF1 CCT2 DNAH7 BLM LIG1 SEC24D TJP1 GOLGA4 GOLGB1 | 3.35e-06 | 777 | 121 | 13 | 35844135 | |
| Pubmed | 3.40e-06 | 9 | 121 | 3 | 24003236 | ||
| Pubmed | Caspase-8 and c-FLIPL associate in lipid rafts with NF-kappaB adaptors during T cell activation. | 3.40e-06 | 9 | 121 | 3 | 17462996 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 3.73e-06 | 444 | 121 | 10 | 34795231 | |
| Pubmed | PRPSAP2 AARS1 MYH9 CKAP5 CCT2 ADAR CCDC88C NEFL IGF2BP2 EIF3C EIF3D | 3.80e-06 | 551 | 121 | 11 | 34728620 | |
| Pubmed | MYO5A CCT2 ITPR3 BLM NEFL PTPN2 GTF2E1 IGF2BP2 TJP1 PHLPP1 EIF3C HSPA6 GOLGA4 KNL1 WDR48 | 3.86e-06 | 1049 | 121 | 15 | 27880917 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PDS5B AARS1 MYH9 ITCH RASA2 MYO5A CKAP5 CASP8 CCT2 ADAR BLM IGF2BP2 RNF20 PRKCD EIF3D HSPA6 GOLGA4 | 4.69e-06 | 1353 | 121 | 17 | 29467282 |
| Pubmed | Conservation and diversity of eukaryotic translation initiation factor eIF3. | 4.84e-06 | 10 | 121 | 3 | 8995409 | |
| Pubmed | Genetic susceptibility to type 2 diabetes is associated with reduced prostate cancer risk. | 5.28e-06 | 33 | 121 | 4 | 20203524 | |
| Pubmed | 7.45e-06 | 285 | 121 | 8 | 32838362 | ||
| Pubmed | 8.83e-06 | 12 | 121 | 3 | 14519125 | ||
| Pubmed | Reconstitution reveals the functional core of mammalian eIF3. | 8.83e-06 | 12 | 121 | 3 | 17581632 | |
| Pubmed | DMXL2 CAPN3 NSD1 APC EIF3CL SULT1C3 RNF20 PAK1 PRKCD STK39 PRKCQ EIF3C | 9.72e-06 | 730 | 121 | 12 | 34857952 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 17548619 | ||
| Pubmed | RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself. | 1.20e-05 | 2 | 121 | 2 | 26275108 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 19488899 | ||
| Pubmed | ADAR1 RNA editing regulates endothelial cell functions via the MDA-5 RNA sensing signaling pathway. | 1.20e-05 | 2 | 121 | 2 | 34969816 | |
| Pubmed | EIF3C Promotes Lung Cancer Tumorigenesis by Regulating the APP/HSPA1A/LMNB1 Axis. | 1.20e-05 | 2 | 121 | 2 | 36157221 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 16033904 | ||
| Pubmed | Cancer predisposition caused by elevated mitotic recombination in Bloom mice. | 1.20e-05 | 2 | 121 | 2 | 11101838 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 37421629 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 21359212 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 26304465 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 34525338 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 28629331 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 29545013 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 38935501 | ||
| Pubmed | Phosphorylation of CARMA1 plays a critical role in T Cell receptor-mediated NF-kappaB activation. | 1.20e-05 | 2 | 121 | 2 | 16356856 | |
| Pubmed | Ripor2 is involved in auditory hair cell stereociliary bundle structure and orientation. | 1.20e-05 | 2 | 121 | 2 | 30280293 | |
| Pubmed | Cardiac valve involvement in ADAR-related type I interferonopathy. | 1.20e-05 | 2 | 121 | 2 | 31772029 | |
| Pubmed | Protein tyrosine phosphatase nonreceptor type 2 controls colorectal cancer development. | 1.20e-05 | 2 | 121 | 2 | 33001862 | |
| Pubmed | Enhanced tumor formation in mice heterozygous for Blm mutation. | 1.20e-05 | 2 | 121 | 2 | 12242442 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 34772697 | ||
| Pubmed | ADAR1-mediated RNA editing is required for thymic self-tolerance and inhibition of autoimmunity. | 1.20e-05 | 2 | 121 | 2 | 30361393 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 30336116 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 19458037 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | PDS5B FLOT2 CENPF CKAP5 APC CCT2 TACC2 EIF3CL BLM FANCB CNOT6L TJP1 EIF3C EIF3D KNL1 | 1.21e-05 | 1155 | 121 | 15 | 20360068 |
| Pubmed | 1.45e-05 | 14 | 121 | 3 | 18599441 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | FLOT2 TBC1D15 CENPF PUM2 CCT2 TACC2 TTC3 ITPR3 BLM NEFL PTPN2 IGF2BP2 AASS SECISBP2 PRKCD PRKCQ GOLGB1 | 1.73e-05 | 1496 | 121 | 17 | 32877691 |
| Pubmed | AARS1 DMXL2 ARHGEF28 PPFIBP1 APC MIB2 RAD54B RNF20 RNF128 PLCE1 WDR48 | 1.78e-05 | 650 | 121 | 11 | 38777146 | |
| Pubmed | 1.81e-05 | 15 | 121 | 3 | 17322308 | ||
| Pubmed | 2.70e-05 | 17 | 121 | 3 | 34752747 | ||
| Pubmed | 2.70e-05 | 17 | 121 | 3 | 33469115 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | PRPSAP2 PDS5B SEC16B DMXL2 MYH9 MYO5A ARID4A PRAMEF19 FBF1 ADAR POLR3F PTPN2 SULT1C3 SECISBP2 STK39 | 2.82e-05 | 1242 | 121 | 15 | 30973865 |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | MYH9 REXO5 MYO5A PRAMEF19 TATDN2 FYCO1 EXOC6B HSPA6 GOLGA4 GOLGB1 | 2.94e-05 | 564 | 121 | 10 | 21565611 |
| Pubmed | 3.00e-05 | 451 | 121 | 9 | 36168627 | ||
| Pubmed | AARS1 TBC1D15 MYH9 ARID4A PPFIBP1 CKAP5 ITPR3 PTPN2 TJP1 GOLGA4 | 3.12e-05 | 568 | 121 | 10 | 37774976 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | FLOT2 MYH9 ITCH MYO5A CENPF PPFIBP1 CKAP5 CCT2 ADAR EIF3CL ITPR3 PTPN2 IGF2BP2 TJP1 EIF3D | 3.24e-05 | 1257 | 121 | 15 | 36526897 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | PRPSAP2 AARS1 MYH9 PPFIBP1 CKAP5 CCT2 TACC2 FNBP1L GTF2E1 TJP1 RNF20 EIF3C EIF3D HSPA6 GOLGA4 GOLGB1 | 3.32e-05 | 1415 | 121 | 16 | 28515276 |
| Pubmed | Disrupted RNA editing in beta cells mimics early-stage type 1 diabetes. | 3.59e-05 | 3 | 121 | 2 | 38128529 | |
| Pubmed | ADAR1-Dependent RNA Editing Promotes MET and iPSC Reprogramming by Alleviating ER Stress. | 3.59e-05 | 3 | 121 | 2 | 32396862 | |
| Pubmed | ADAR1p150 prevents MDA5 and PKR activation via distinct mechanisms to avert fatal autoinflammation. | 3.59e-05 | 3 | 121 | 2 | 37797622 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 36172730 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 18550547 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 20971075 | ||
| Pubmed | The phenotype of the most common human ADAR1p150 Zα mutation P193A in mice is partially penetrant. | 3.59e-05 | 3 | 121 | 2 | 36975179 | |
| Pubmed | A new member of the protein kinase C family, nPKC theta, predominantly expressed in skeletal muscle. | 3.59e-05 | 3 | 121 | 2 | 1508194 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 10607827 | ||
| Pubmed | Clinical and genetic findings in an Ashkenazi Jewish population with colorectal neoplasms. | 3.59e-05 | 3 | 121 | 2 | 15959913 | |
| Pubmed | RECQL5 and BLM exhibit divergent functions in cells defective for the Fanconi anemia pathway. | 3.59e-05 | 3 | 121 | 2 | 25520194 | |
| Pubmed | ADAR1 Regulates Early T Cell Development via MDA5-Dependent and -Independent Pathways. | 3.59e-05 | 3 | 121 | 2 | 32169840 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 32603639 | ||
| Pubmed | Bringing statistics up to speed with data in analysis of lymphocyte motility. | 3.59e-05 | 3 | 121 | 2 | 25973755 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 22744337 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 18446227 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 22403440 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 23811286 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 14673152 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 18832381 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 34482352 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | PDS5B FLOT2 AARS1 TBC1D15 MYH9 CENPF CKAP5 CCT2 TTC3 ADAR EIF3CL RNF20 PRKCD EIF3C EIF3D GOLGA4 | 3.61e-05 | 1425 | 121 | 16 | 30948266 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | PRPSAP2 PDS5B CENPF ANXA11 ADAR LIG1 PTPN2 IGF2BP2 RNF20 EIF3C EIF3D | 3.68e-05 | 704 | 121 | 11 | 29955894 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 3.83e-05 | 582 | 121 | 10 | 20467437 | |
| Pubmed | FLOT2 TBC1D15 MYH9 PPFIBP1 CKAP5 ANKRD26 APC CCT2 PRUNE1 GOLGA4 GOLGB1 | 3.88e-05 | 708 | 121 | 11 | 39231216 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | FLOT2 MYH9 ANXA11 CKAP5 CCT2 ADAR NEFL RNF20 EIF3C EIF3D HSPA6 GOLGB1 | 4.17e-05 | 847 | 121 | 12 | 35235311 |
| Pubmed | PRPSAP2 FLOT2 DMXL2 MYH9 MYO5A CKAP5 APC TACC2 MIB2 EIF3CL PRUNE1 PTPN2 TJP1 EIF3C | 4.40e-05 | 1139 | 121 | 14 | 36417873 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | FLOT2 PPFIBP1 CKAP5 ANKRD26 APC CASP8 CCT2 AZI2 DNAH7 CCDC88C TJP1 AASS | 4.46e-05 | 853 | 121 | 12 | 28718761 |
| Pubmed | Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan. | 4.55e-05 | 183 | 121 | 6 | 31932471 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PRPSAP2 AARS1 TBC1D15 MYH9 CCT2 PGGT1B EIF3CL LIG1 SEC24D GTF2E1 DCUN1D1 RNF20 STK39 EIF3C EIF3D HSPA6 | 4.62e-05 | 1455 | 121 | 16 | 22863883 |
| Pubmed | PTEN identified as important risk factor of chronic obstructive pulmonary disease. | 5.19e-05 | 374 | 121 | 8 | 19625176 | |
| Pubmed | Shared and distinct genetic variants in type 1 diabetes and celiac disease. | 5.22e-05 | 21 | 121 | 3 | 19073967 | |
| Pubmed | 5.47e-05 | 59 | 121 | 4 | 32382008 | ||
| Pubmed | Global phosphoproteome of HT-29 human colon adenocarcinoma cells. | 5.47e-05 | 59 | 121 | 4 | 16083285 | |
| Interaction | ZC3H7A interactions | 4.62e-06 | 215 | 117 | 9 | int:ZC3H7A | |
| Interaction | PHLPP1 interactions | 2.48e-05 | 333 | 117 | 10 | int:PHLPP1 | |
| Interaction | SIRT7 interactions | PDS5B AARS1 MYH9 MYO5A CENPF ANXA11 CKAP5 NSD1 CCT2 ITPR3 BLM NEFL IGF2BP2 TJP1 EIF3D | 2.68e-05 | 744 | 117 | 15 | int:SIRT7 |
| Interaction | CCDC8 interactions | FLOT2 TBC1D15 MYO5A ANXA11 CKAP5 CCT2 ITPR3 NEFL IGF2BP2 DNAH12 TJP1 EIF3C EIF3D GOLGB1 | 2.73e-05 | 656 | 117 | 14 | int:CCDC8 |
| Interaction | NAA40 interactions | FLOT2 AARS1 MYH9 CKAP5 ANKRD26 PUM2 CCT2 TACC2 ADAR PRUNE1 GTF2E1 IGF2BP2 TJP1 EIF3C EIF3D GOLGB1 KNL1 | 4.92e-05 | 978 | 117 | 17 | int:NAA40 |
| Interaction | LAMP2 interactions | PDS5B FLOT2 MYO5A PPFIBP1 ARFGEF1 FYCO1 ITPR3 VAC14 PRKCD STK39 PRKCQ GOLGA4 GOLGB1 | 5.37e-05 | 609 | 117 | 13 | int:LAMP2 |
| Interaction | AKT1 interactions | MYH9 ITCH ARHGEF28 CCT2 TTC3 ITPR3 RNF20 PAK1 PHLPP1 CARD11 PRKCQ HSPA6 WDR48 | 6.13e-05 | 617 | 117 | 13 | int:AKT1 |
| Interaction | EIF4ENIF1 interactions | 6.45e-05 | 300 | 117 | 9 | int:EIF4ENIF1 | |
| Interaction | YWHAZ interactions | BDP1 DMXL2 MYH9 RIPOR2 ARHGEF28 COL6A6 MYO5A PPFIBP1 CKAP5 ANKRD26 APC TACC2 NEB CCDC88C NEFL TJP1 AASS SULT1C3 PAK1 PRKCD | 6.84e-05 | 1319 | 117 | 20 | int:YWHAZ |
| Interaction | CARD11 interactions | 8.39e-05 | 40 | 117 | 4 | int:CARD11 | |
| GeneFamily | Schlafen family | 3.71e-04 | 7 | 77 | 2 | 1110 | |
| GeneFamily | C2 domain containing protein kinases | 7.88e-04 | 10 | 77 | 2 | 835 | |
| GeneFamily | Eukaryotic translation initiation factor 3 | 1.35e-03 | 13 | 77 | 2 | 1121 | |
| GeneFamily | Myosin heavy chains | 1.81e-03 | 15 | 77 | 2 | 1098 | |
| GeneFamily | Dyneins, axonemal | 2.34e-03 | 17 | 77 | 2 | 536 | |
| GeneFamily | EF-hand domain containing | 2.43e-03 | 219 | 77 | 5 | 863 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PDS5B DMXL2 ITCH ARID4A CENPF CKAP5 APC ARFGEF1 PUM2 CASP8 FNBP1L BLM PTPN2 SEC24D PHLPP1 STK39 GOLGA4 PLCE1 | 8.12e-08 | 856 | 121 | 18 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | CENPF CKAP5 ARFGEF1 PUM2 CASP8 FNBP1L BLM PTPN2 PHLPP1 STK39 GOLGA4 | 1.10e-05 | 466 | 121 | 11 | M13522 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | BDP1 PDS5B MYO5A APC ARFGEF1 BLM IFIH1 DCUN1D1 RAD54B RNF20 GOLGA4 GOLGB1 KNL1 | 1.11e-05 | 656 | 121 | 13 | M18979 |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP | 1.81e-05 | 176 | 121 | 7 | M2981 | |
| Coexpression | GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_DN | 3.98e-05 | 199 | 121 | 7 | M316 | |
| Coexpression | GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_DN | 3.98e-05 | 199 | 121 | 7 | M8211 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | BDP1 RIPOR2 COL6A6 MYO5A ARID4A PPFIBP1 WNT7A APC TATDN2 ARFGEF1 FNBP1L NEB TTC3 CNOT6L ZFHX2 RAB11FIP4 | 5.05e-05 | 1106 | 121 | 16 | M39071 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | MYO5A ARID4A CENPF WNT7A CKAP5 NSD1 ANKRD26 APC AZI2 FNBP1L TTC3 CCDC88C LIG1 NEFL NSUN6 RAD54B RNF20 PAK1 ZFHX2 PHLPP1 STK39 MYRF KNL1 PLCE1 | 4.32e-07 | 1370 | 118 | 24 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | BDP1 PDS5B ITCH ARID4A CENPF RDH14 CKAP5 APC FNBP1L LIG1 PTPN2 GTF2E1 RNF20 GOLGB1 KNL1 | 2.17e-06 | 629 | 118 | 15 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | BDP1 MYO5A ARID4A CENPF WNT7A CKAP5 ANKRD26 ZKSCAN2 AZI2 BLM CCDC88C NEFL VAC14 PAK1 ZFHX2 PHLPP1 DNAI4 GOLGA4 KNL1 | 2.18e-06 | 989 | 118 | 19 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3 | CENPF FNBP1L TTC3 BLM LIG1 IGF2BP2 DCUN1D1 TJP1 RAD54B PAK1 PRKCQ KNL1 | 4.25e-06 | 423 | 118 | 12 | GSM791126_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | BDP1 MYO5A ARID4A CENPF RDH14 CKAP5 NSD1 ANKRD26 APC PUM2 FNBP1L POLR3F BLM CCDC88C LIG1 CNOT6L RAD54B RNF20 PAK1 RNF128 KNL1 | 5.37e-06 | 1257 | 118 | 21 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | EPHX2 RIPOR2 MYO5A CENPF WNT7A CKAP5 ANKRD26 APC FYCO1 FNBP1L BLM CCDC88C NEFL RAD54B PAK1 PHLPP1 DNAI4 RAB11FIP4 KNL1 | 5.94e-06 | 1060 | 118 | 19 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 9.49e-06 | 311 | 118 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | BDP1 PDS5B ITCH ARID4A APC ARFGEF1 PGGT1B LIG1 PTPN2 GTF2E1 RNF20 GOLGB1 KNL1 | 1.55e-05 | 564 | 118 | 13 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | BDP1 MYO5A ARID4A CENPF WNT7A RDH14 CKAP5 NSD1 ANKRD26 APC PUM2 FNBP1L POLR3F BLM CCDC88C LIG1 CNOT6L RAD54B RNF20 PAK1 RNF128 KNL1 | 1.57e-05 | 1459 | 118 | 22 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | EPHX2 RIPOR2 MYO5A CENPF WNT7A CKAP5 ANKRD26 APC FYCO1 FNBP1L BLM S100A5 CCDC88C NEFL RAD54B PAK1 PHLPP1 DNAI4 RAB11FIP4 KNL1 | 9.83e-05 | 1414 | 118 | 20 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | Fetal Liver, SC.STSL.FL, IgM- CD24- CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Fetal Liver, avg-2 | 9.86e-05 | 410 | 118 | 10 | GSM791122_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | 9.86e-05 | 410 | 118 | 10 | GSM538387_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 1.00e-04 | 192 | 118 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | BDP1 ARID4A CENPF WNT7A CKAP5 ANKRD26 CCDC88C NEFL PHLPP1 GOLGA4 KNL1 | 1.06e-04 | 498 | 118 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | BDP1 DMXL2 MYO5A ARID4A CENPF WNT7A CKAP5 ANKRD26 AZI2 RAD54B PAK1 DNAI4 GOLGA4 KNL1 | 2.13e-04 | 831 | 118 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| ToppCell | COVID-19-T_cells|COVID-19 / group, cell type (main and fine annotations) | 5.44e-08 | 191 | 121 | 8 | 7f64add931b64b8d35836fa6bee9ebab593844d3 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 7.18e-08 | 198 | 121 | 8 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | LV-17._Lymphocyte|World / Chamber and Cluster_Paper | 4.81e-07 | 173 | 121 | 7 | 212f013ff761cbab24a537071739867c08c402a4 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.05e-07 | 179 | 121 | 7 | 9dea57494d59abd6e8abf34e31faf53462ea0fa0 | |
| ToppCell | LV-17._Lymphocyte|LV / Chamber and Cluster_Paper | 6.51e-07 | 181 | 121 | 7 | 81fafa69c8c240250a667a5f3b321e8be1b9a288 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.82e-07 | 186 | 121 | 7 | 71e87c4c755ab607689cb050f5a363cb520a0f53 | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 8.11e-07 | 187 | 121 | 7 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | COVID-19-T_cells-CD8+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 8.71e-07 | 189 | 121 | 7 | 2c018d6120f65f0b2704b483bc9da1c0984872e3 | |
| ToppCell | COVID-19-T_cells-NK_cells|COVID-19 / group, cell type (main and fine annotations) | 8.71e-07 | 189 | 121 | 7 | b699152dfbb8cd8ed724e1e5a51838f29b681b62 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.04e-06 | 194 | 121 | 7 | 3d6f2d190dd50804afea299957cc44c2bb756134 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 3.62e-06 | 151 | 121 | 6 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.53e-06 | 157 | 121 | 6 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.23e-06 | 161 | 121 | 6 | 2165897924c790fec43502283f1df221c56c1e9f | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.68e-06 | 168 | 121 | 6 | 96f7411474edd673b8d3ee6b8a8bb185c246daaf | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.91e-06 | 169 | 121 | 6 | f06118754fa62c580b4bcbecff6f9e5fdc2106a0 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-06 | 173 | 121 | 6 | 20a20429aa898097d5ec4880ed64846558b5890f | |
| ToppCell | Children_(3_yrs)-Immune-natural_killer_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.16e-06 | 174 | 121 | 6 | 33d6b81f31bfcb9c4b30206d88e20b9a94fba4a2 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.16e-06 | 174 | 121 | 6 | 9bb8159a62640756d18ecbade3bf32bcbb7dd590 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.16e-06 | 174 | 121 | 6 | e70cc623a3a6aceec813ed852fec0c4240561133 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.16e-06 | 174 | 121 | 6 | b6725086fe5a2b057c7c495ec63c970ac52c2580 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.43e-06 | 175 | 121 | 6 | a6913f992a1ea20b43e5adeca3ede3a6fda820ad | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.59e-06 | 179 | 121 | 6 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | ASK454-Epithelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.05e-05 | 182 | 121 | 6 | ab15316cff989b61ff397a866d7ca8b49c13e981 | |
| ToppCell | RA-17._Lymphocyte|RA / Chamber and Cluster_Paper | 1.05e-05 | 182 | 121 | 6 | 257a7847917b6ea1d60608183d90300bfd028758 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 1.12e-05 | 184 | 121 | 6 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | Control-T_cells-CD8+_T_cells|Control / group, cell type (main and fine annotations) | 1.16e-05 | 185 | 121 | 6 | 02ab64c0166c0646d1d4c6ed110ef0b75a1096d0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-05 | 187 | 121 | 6 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 1.23e-05 | 187 | 121 | 6 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | LPS_only-Lymphocytic_NKT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-05 | 188 | 121 | 6 | bbe65b1c11c88ab62d8485cfc3a913ff9da89aad | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.31e-05 | 189 | 121 | 6 | df30478b288084a1bd48f660409dcc784040897c | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.31e-05 | 189 | 121 | 6 | d05e043d0874b8563b9f5514f6c884b35c603e3a | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.35e-05 | 190 | 121 | 6 | 0adb24dafa077156bbc73a8d8cbf3d9eeb6e08df | |
| ToppCell | IPF-Lymphoid-T|IPF / Disease state, Lineage and Cell class | 1.35e-05 | 190 | 121 | 6 | d57df208aaf7a5554899bb9107c80b443fd0cf93 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 190 | 121 | 6 | b99271d139c8d01e20feb95d99f79c9b2756b4cb | |
| ToppCell | Control-T_cells-CD4+_T_cells|Control / group, cell type (main and fine annotations) | 1.35e-05 | 190 | 121 | 6 | 0733be5e54fe15d6d6ea51c154a95258e83f1b92 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.35e-05 | 190 | 121 | 6 | 05455775845f4ded5c27e7b83242078d23162aaf | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.39e-05 | 191 | 121 | 6 | 683e5c7e6173644f01e67c98ab7b75d7cb9cce99 | |
| ToppCell | Immune-natural_killer_cell|World / Lineage, Cell type, age group and donor | 1.43e-05 | 192 | 121 | 6 | 68121a6ef4115a93d87aad8802ef9b27d793d8c0 | |
| ToppCell | IPF-Lymphoid-T|World / Disease state, Lineage and Cell class | 1.43e-05 | 192 | 121 | 6 | b25ba1f3bc842c22602b2aeed3b1b5082863e4fa | |
| ToppCell | Control-Lymphoid-T|Control / Disease state, Lineage and Cell class | 1.47e-05 | 193 | 121 | 6 | af928046ccd1ca874be1534aef6ca7f27d90bc46 | |
| ToppCell | IPF-Lymphoid-T_Cytotoxic|World / Disease state, Lineage and Cell class | 1.47e-05 | 193 | 121 | 6 | 35c902a983d7f1156a74fe68ee366609029833b3 | |
| ToppCell | Children_(3_yrs)-Immune-natural_killer_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.47e-05 | 193 | 121 | 6 | 1cb666375bc4e1b11a146d20896c9b5ae6fd0887 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.51e-05 | 194 | 121 | 6 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.56e-05 | 195 | 121 | 6 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | COVID-19-lung-NK/NKT|lung / Disease (COVID-19 only), tissue and cell type | 1.56e-05 | 195 | 121 | 6 | 3ab941a369e3815f338890b116dc77aefa054098 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.56e-05 | 195 | 121 | 6 | 9b7157b5e4b81bc35b0e6d9b954279160ea57324 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-05 | 195 | 121 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 1.61e-05 | 196 | 121 | 6 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 1.61e-05 | 196 | 121 | 6 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.65e-05 | 197 | 121 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Epithelial_cells-AT1-AT2_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.70e-05 | 198 | 121 | 6 | fbc46b20bcd44f2083170aacbc6f5dd00fba685c | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.70e-05 | 198 | 121 | 6 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 1.75e-05 | 199 | 121 | 6 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.80e-05 | 200 | 121 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-05 | 200 | 121 | 6 | 02c4169a23e5aaa0d4bfc78b51ba19ce8157dc3e | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-05 | 200 | 121 | 6 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | (08)_PNEC-(2)_48hpi|(08)_PNEC / shred by cell type and Timepoint | 4.32e-05 | 142 | 121 | 5 | e95d34170f5053678e0dd9793e68d93c03b05822 | |
| ToppCell | LPS-IL1RA-Myeloid_granulocytic|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.36e-05 | 154 | 121 | 5 | d55fb73461885e1e02061a344ff89624ef4de487 | |
| ToppCell | LPS-IL1RA-Myeloid_granulocytic-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.36e-05 | 154 | 121 | 5 | 43735f7c58cac51855ded486ee8d8729a1b9909e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.31e-05 | 163 | 121 | 5 | 3f434015c0cbefb31eeda133c34f75384c5f7e22 | |
| ToppCell | Ciliated_cells-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 8.56e-05 | 164 | 121 | 5 | fd30c55d0d75ef8b9396435d836187168095152b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.32e-05 | 167 | 121 | 5 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.32e-05 | 167 | 121 | 5 | 108ae6221c6edc63c0ec42c42471b3a15a594043 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.86e-05 | 169 | 121 | 5 | 0bc8ef341ce307b19018d4ac8de0a4d04254209d | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.86e-05 | 169 | 121 | 5 | c5015ddb838849ea892a2cae5a739b554eb6d793 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.86e-05 | 169 | 121 | 5 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 1.01e-04 | 170 | 121 | 5 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | ileum|World / shred on tissue and cell subclass | 1.01e-04 | 170 | 121 | 5 | 9f1211bd4287620e19a59f21e6ecdca3e42e0260 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 173 | 121 | 5 | a25459b8140b0dbcb73e3b4cc1407b679229f25c | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.13e-04 | 174 | 121 | 5 | 33386750842c47ad7e7286d0f26a556da1a2de02 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-04 | 174 | 121 | 5 | dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-iNKT/MAIT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-04 | 174 | 121 | 5 | 61aa89b56ebda0eba1ba675d5f036992967f670f | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-regulatory_T_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.13e-04 | 174 | 121 | 5 | 9344d4e76d7d9429aea87d3c0b98246200d16014 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.16e-04 | 175 | 121 | 5 | 06af6629766e2054e6995e8cdb3907658fec49d3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 175 | 121 | 5 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-04 | 175 | 121 | 5 | 98cb577df466700e72d1bbc6689205ccf2e7fcba | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 175 | 121 | 5 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-04 | 175 | 121 | 5 | 9de288c338cee67be0e9b836c87799bbc1db1c38 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.22e-04 | 177 | 121 | 5 | 8a74f5e72de605774111057bd87a7e7e4a6385cd | |
| ToppCell | Ciliated_cells-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.22e-04 | 177 | 121 | 5 | c38138fb5ad9766c2d240811210c854338cd612e | |
| ToppCell | Severe-CD4+_T_activated|World / Disease group and Cell class | 1.26e-04 | 178 | 121 | 5 | ef6111238703579a34bd6948bd9d4ca6b7e16063 | |
| ToppCell | LA-17._Lymphocyte|World / Chamber and Cluster_Paper | 1.26e-04 | 178 | 121 | 5 | 34ec499d03cc198cfefa19a724d4c81974052f65 | |
| ToppCell | LPS_only-Lymphocytic_NKT-iNKT/MAIT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-04 | 179 | 121 | 5 | de3ddc1264e43727be50d69b81cc84a3c91812a2 | |
| ToppCell | LPS_only-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-04 | 179 | 121 | 5 | def981e97e3ff9019910c9af3861ca0d08eb0d0f | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-hematologic-hematopoietic_progenitor|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.32e-04 | 180 | 121 | 5 | f598bb9df0d784120847fada2d9a2a88b8b68cd1 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-hematologic-hematopoietic_progenitor-hematopoietic_stem_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.32e-04 | 180 | 121 | 5 | b4fa047f271c7b56940bdc85c912f50aa5b5ca82 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-04 | 180 | 121 | 5 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-04 | 180 | 121 | 5 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df | |
| ToppCell | Adult-Immune-T_lymphocyte-D122|Adult / Lineage, Cell type, age group and donor | 1.32e-04 | 180 | 121 | 5 | 06c371d0f0c5a7b234dd143e98800e19af95a8b5 | |
| ToppCell | COVID-19-kidney-NK|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.36e-04 | 181 | 121 | 5 | 8906ee8a7a1616dfe8c3b5c73988416641213629 | |
| ToppCell | COVID-19-T_cells-Tregs|COVID-19 / group, cell type (main and fine annotations) | 1.36e-04 | 181 | 121 | 5 | 534659cf754326c6a73c0daa30e9d610612a0292 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 181 | 121 | 5 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | LA-17._Lymphocyte|LA / Chamber and Cluster_Paper | 1.36e-04 | 181 | 121 | 5 | 3fd9f805fa46141b0fa7023ee5d8688d338635d5 | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.39e-04 | 182 | 121 | 5 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-04 | 183 | 121 | 5 | b1336eac5adbffade4cef3e0ce3de75a781ae365 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-04 | 183 | 121 | 5 | cc57dcb59c68d68a546dc108dd9e009b2aab8da5 | |
| ToppCell | RA-17._Lymphocyte|World / Chamber and Cluster_Paper | 1.43e-04 | 183 | 121 | 5 | 6397f684a50346fc42cccb5afbe10350f4b2d9b0 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.47e-04 | 184 | 121 | 5 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 1.47e-04 | 184 | 121 | 5 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.47e-04 | 184 | 121 | 5 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.12e-04 | 49 | 72 | 4 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.12e-04 | 49 | 72 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.38e-04 | 50 | 72 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Drug | Clorgyline | 3.30e-06 | 168 | 121 | 8 | ctd:D003010 | |
| Disease | primary immunodeficiency disease (is_implicated_in) | 2.19e-05 | 42 | 115 | 4 | DOID:612 (is_implicated_in) | |
| Disease | congenital diaphragmatic hernia (is_implicated_in) | 8.99e-05 | 4 | 115 | 2 | DOID:3827 (is_implicated_in) | |
| Disease | Sensorineural Hearing Loss (disorder) | 9.65e-05 | 23 | 115 | 3 | C0018784 | |
| Disease | obesity (implicated_via_orthology) | 2.03e-04 | 215 | 115 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | Aicardi-Goutieres Syndrome 2 | 2.24e-04 | 6 | 115 | 2 | C3489724 | |
| Disease | AICARDI-GOUTIERES SYNDROME 1 | 2.24e-04 | 6 | 115 | 2 | C0796126 | |
| Disease | Pseudo-TORCH syndrome | 3.12e-04 | 7 | 115 | 2 | C3489725 | |
| Disease | able to hear with hearing aids | 3.12e-04 | 7 | 115 | 2 | EFO_0009720 | |
| Disease | Autoimmune Lymphoproliferative Syndrome | 4.15e-04 | 8 | 115 | 2 | C1328840 | |
| Disease | X-24747 measurement | 4.15e-04 | 8 | 115 | 2 | EFO_0022135 | |
| Disease | Myopathies, Nemaline | 4.15e-04 | 8 | 115 | 2 | C0206157 | |
| Disease | AICARDI-GOUTIERES SYNDROME | 4.15e-04 | 8 | 115 | 2 | C0393591 | |
| Disease | HEPATOCELLULAR CARCINOMA | 5.32e-04 | 9 | 115 | 2 | 114550 | |
| Disease | Aicardi-Goutieres syndrome (is_implicated_in) | 5.32e-04 | 9 | 115 | 2 | DOID:0050629 (is_implicated_in) | |
| Disease | Hepatocellular carcinoma | 5.32e-04 | 9 | 115 | 2 | cv:C2239176 | |
| Disease | lymphocyte:monocyte ratio | 9.49e-04 | 288 | 115 | 6 | EFO_0600088 | |
| Disease | Charcot-Marie-Tooth disease (is_implicated_in) | 9.69e-04 | 12 | 115 | 2 | DOID:10595 (is_implicated_in) | |
| Disease | Intestinal Neoplasms | 9.69e-04 | 12 | 115 | 2 | C0021841 | |
| Disease | Intestinal Cancer | 9.69e-04 | 12 | 115 | 2 | C0346627 | |
| Disease | inflammatory biomarker measurement, YKL40 measurement | 1.05e-03 | 51 | 115 | 3 | EFO_0004869, EFO_0004872 | |
| Disease | daytime rest measurement | 1.07e-03 | 295 | 115 | 6 | EFO_0007828 | |
| Disease | esophageal squamous cell carcinoma | 1.14e-03 | 13 | 115 | 2 | EFO_0005922 | |
| Disease | mean reticulocyte volume | 1.16e-03 | 799 | 115 | 10 | EFO_0010701 | |
| Disease | ecosanoids measurement | 1.31e-03 | 55 | 115 | 3 | EFO_0020044 | |
| Disease | HbA1c measurement | 1.33e-03 | 675 | 115 | 9 | EFO_0004541 | |
| Disease | hyperinsulinism (biomarker_via_orthology) | 1.53e-03 | 15 | 115 | 2 | DOID:2018 (biomarker_via_orthology) | |
| Disease | Eye Abnormalities | 1.97e-03 | 17 | 115 | 2 | C0015393 | |
| Disease | Charcot-Marie-Tooth disease type 2 | 1.97e-03 | 17 | 115 | 2 | cv:C0270914 | |
| Disease | serum alanine aminotransferase measurement | PDS5B ITCH CASP8 PIWIL4 FNBP1L PRUNE1 ABCC2 MYRF HSPA6 PLCE1 | 2.15e-03 | 869 | 115 | 10 | EFO_0004735 |
| Disease | age at initiation of smoking | 2.21e-03 | 66 | 115 | 3 | EFO_0021784 | |
| Disease | cortical surface area measurement | ITCH PPFIBP1 WNT7A RDH14 APC FNBP1L DNAH7 FOCAD CCDC88C TJP1 EXOC6B RAB11FIP4 PLCE1 | 2.26e-03 | 1345 | 115 | 13 | EFO_0010736 |
| Disease | C-reactive protein measurement | RPGRIP1 SEC16B DMXL2 ARHGEF28 MIB2 FNBP1L ADAR EIF3CL PTPN2 EXOC6B NKPD1 EIF3C | 2.64e-03 | 1206 | 115 | 12 | EFO_0004458 |
| Disease | cognitive function measurement, self reported educational attainment | 2.73e-03 | 355 | 115 | 6 | EFO_0004784, EFO_0008354 | |
| Disease | X-24309 measurement | 2.73e-03 | 20 | 115 | 2 | EFO_0800872 | |
| Disease | cholangiocarcinoma (is_implicated_in) | 3.31e-03 | 22 | 115 | 2 | DOID:4947 (is_implicated_in) | |
| Disease | Granulomatous Slack Skin | 3.31e-03 | 22 | 115 | 2 | C0376407 | |
| Disease | Lymphoma, T-Cell, Cutaneous | 3.61e-03 | 23 | 115 | 2 | C0079773 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLLDVSIKMEKDSGC | 531 | A9YTQ3 | |
| LELMRKECSDLKIEL | 176 | Q9H6S1 | |
| ELKEGECSKEQMLSC | 506 | A6H8Y1 | |
| DEEDMEPCLTGTKVK | 566 | P29374 | |
| GDLEEGMLAVVKCLK | 416 | P50995 | |
| ETKGLMDENCILKAD | 506 | Q5CZ79 | |
| NVPKCDEILMEEIKD | 901 | Q5VTR2 | |
| KGLECLVSILKCMVE | 611 | Q9Y6D6 | |
| KIMTEKELLAVACEQ | 76 | Q14254 | |
| GIREAECKKEMLDVK | 191 | Q14254 | |
| MDICKQEEKLGFLVA | 531 | Q9UDR5 | |
| TECSLLLKEMDDGLL | 1751 | Q8IYW2 | |
| AGSLKDAIEVCLEKM | 1731 | Q8TDJ6 | |
| GMECKDSVSLLKIQD | 716 | Q9UPS8 | |
| MTELGCDSIEKLKAQ | 126 | Q96GG9 | |
| EKIEEGQTLMICGKE | 176 | Q9Y620 | |
| ESLLACLKMDDEKVA | 671 | Q9NTI5 | |
| KCIPGSIKLDSEEDM | 441 | Q96L73 | |
| LKLQKMEEACGTIAV | 771 | Q15283 | |
| LCILKDVMEKLSTGV | 301 | O95825 | |
| MKGCEELLKDVLSVE | 81 | Q86YS3 | |
| KKTEMEIVDGLIEGC | 236 | O95980 | |
| TCLVLMEKGDDINIK | 231 | P17706 | |
| SEMVKELDGHVLKCV | 831 | Q8TB72 | |
| TKDLMESEEKLCIKV | 1651 | Q14573 | |
| LCLIKDMIATVDLKV | 1031 | Q8N1W1 | |
| IILDCVNMDLKIGKA | 176 | Q86TP1 | |
| LKKDVVLMDDDVECT | 411 | Q04759 | |
| FSITCLVDEEEMKKL | 536 | P19827 | |
| KKDVVLIDDDVECTM | 381 | Q05655 | |
| KLVCKMKGEGVEIVD | 286 | Q86W92 | |
| LLFGCEKEEMNKEIT | 1081 | Q13439 | |
| SEICLLKSGELMIKV | 1336 | Q9BQS8 | |
| SMEEIKKVLLLVLGC | 116 | Q9P219 | |
| LESELQMLKKECETL | 996 | Q9P219 | |
| LDCQITIKDMEKGDI | 1381 | Q5H8C1 | |
| VLDDNKKLCLMSGEI | 1631 | Q6ZR08 | |
| DDDITDDIMCAKKIL | 101 | P00709 | |
| DDIMCAKKILDIKGI | 106 | P00709 | |
| LEGSAMLLCDKDEEK | 1341 | Q8NG31 | |
| SDKVMVLDNGKIIEC | 1501 | Q92887 | |
| LKEFMDACDILGLSK | 156 | Q6JVE6 | |
| GKQACVLMIKALELD | 736 | P35579 | |
| EGKELVIAMEELKQC | 106 | Q9Y2D4 | |
| VEACASAEIEIMKKL | 331 | Q9Y6M1 | |
| CFDGTKAVKLDMVED | 291 | Q8TEA1 | |
| DIESALADCRLGKKM | 166 | Q9H6S3 | |
| MVLLGLKECCLSEEE | 181 | Q8NB91 | |
| CLEMDVEKRGSAKEL | 501 | Q13153 | |
| KELEVLLCGMQEIDL | 776 | Q96J02 | |
| MKIRDVTKCLEEFEL | 71 | Q99613 | |
| MKIRDVTKCLEEFEL | 71 | B5ME19 | |
| KELGIEICLMYIEIE | 106 | Q14008 | |
| LEEQKSVMLKCGEER | 866 | Q8TES7 | |
| EVLCKEMVTFLDKLG | 311 | P34913 | |
| REEMVKKCLGELTEV | 1211 | P54132 | |
| KCLEGMILAAKSVDE | 246 | Q5T0N5 | |
| LEFLDMAEIKEKICD | 291 | P55265 | |
| VQLMTKIEACIELEK | 1816 | P49454 | |
| LRCVIDICMKLEEGK | 491 | O15371 | |
| VLDDNKKLCLMSGEI | 1706 | Q8WXX0 | |
| LVMEAICILKGIKAD | 2706 | Q8WXX0 | |
| VDKLLVRDVLDKCME | 126 | Q9BYX4 | |
| EEISKCKLDDDMNLL | 126 | Q14790 | |
| KDVQCDKIIMEDKGI | 301 | Q5VTH9 | |
| MLKELFLKVDSDCEG | 91 | A8MWE9 | |
| EIEKLLMEKCSELSA | 181 | Q1MX18 | |
| CMELSKKIAERLGVE | 31 | O60256 | |
| VLMGDKCEKVQDLLL | 381 | P17066 | |
| LKLLMEEDRTSDICK | 2266 | A6NE01 | |
| IAGDDMEICADELKK | 661 | P20807 | |
| MEICADELKKVLNTV | 666 | P20807 | |
| LEQSVKDSCEGLMVK | 711 | P18858 | |
| KDSCEGLMVKTLDVD | 716 | P18858 | |
| DLELKCSTLGKDCEM | 346 | Q9BXL7 | |
| KVDCEIDKVDLVFLM | 991 | A6NMZ7 | |
| ISCKEKVEEILNMLT | 1056 | Q5VW36 | |
| DKVKCLLDTDVLREM | 261 | Q96AX9 | |
| CLMGKLEEVFSEKEL | 231 | P53609 | |
| SCVKEEDMLELLKFD | 41 | P29083 | |
| EIRKMCEVVLGEFLK | 231 | Q08AM6 | |
| GIHCALEIAKVMKEE | 731 | P0C7P3 | |
| PKADSEKMCIEIVSL | 1111 | Q96KN7 | |
| LDMILNDGDVEKCKR | 66 | Q6IMI6 | |
| CREADEDLLEIMKKF | 631 | Q93075 | |
| QLGFMCEVKKEVELL | 201 | Q17RQ9 | |
| EECKDLIKSMLREEL | 81 | P0C2Y1 | |
| KELCEVLDGASGLMK | 711 | Q9P212 | |
| MDVCLKEKSVDEDLS | 151 | Q5SWL8 | |
| GIDVCKDALSKDVMV | 621 | Q7Z3Z4 | |
| MCKCDILKALGIEVD | 316 | Q8TEB7 | |
| MLSKEVDACVTDLLK | 636 | Q96T21 | |
| CKLIEEVMIGEDKLI | 346 | P78371 | |
| DDLEGSLEQEKKLCM | 1036 | Q9Y623 | |
| CELGISKVELSMEDI | 221 | Q9H1D9 | |
| CKEEELLPKAMDESV | 306 | Q9HBH5 | |
| EVMNLDDILKCKPAV | 631 | Q9Y4F9 | |
| GLVKLICEELKTMLE | 456 | O94855 | |
| ICEELKTMLEKIPKE | 461 | O94855 | |
| ALMECALEVKKESTL | 571 | P25054 | |
| KKGIMEEIVNCDADI | 221 | Q96LI5 | |
| LDSVIEMCVKDVLLK | 831 | Q8N2E2 | |
| DKKVKEALDELCLMT | 381 | Q9P243 | |
| CEEKAPVLKMELDRS | 291 | Q8TAF3 | |
| MLDCISEEVGLKKRV | 1886 | Q9C0A1 | |
| KELACKMALELLTQE | 111 | P49588 | |
| GCKLLEDMVEKTINS | 21 | O75556 | |
| CVMDELVKPENKILD | 256 | Q96IC2 | |
| TKIVMEDCNLLEELK | 206 | P53804 | |
| MKSQEEVEVAGIKLC | 1 | Q6ECI4 | |
| EVEVAGIKLCKAMSL | 6 | Q6ECI4 | |
| LKQLICEEMDSVRKG | 406 | Q8IYM2 | |
| IEELTKICDELIAKM | 2931 | O95359 | |
| MKRDGTIKENCDLII | 56 | A2RU48 | |
| MKIDVEDILCKAEAI | 596 | Q8TC07 | |
| ELKDCIEKKTMEGRS | 66 | P57060 | |
| VGSDIAELLMQDCKK | 381 | Q96JE7 | |
| DKEKGETLLSPLVMC | 1686 | Q07157 | |
| EAGRKILEENMKLEC | 186 | O00755 | |
| APLEVEGCLIMKVEK | 11 | Q63HK3 | |
| PEVLEKLTAVDKLCM | 776 | O60346 | |
| ELIKKELCLGEMKES | 36 | P33763 | |
| ELCLGEMKESSIDDL | 41 | P33763 | |
| LEKCQTSMDELLKEI | 96 | Q9UEW8 | |
| LCEMKQKPEEIGEES | 1461 | Q14789 | |
| GCAEEMEEKAAPLLK | 41 | Q96L15 | |
| SKLGILDLLDEECKM | 501 | Q9Y4I1 | |
| LDLLDEECKMPKGTD | 506 | Q9Y4I1 | |
| MENVGAVKELCKLTD | 676 | Q9Y2G1 | |
| VDMLGVVLAKKCQEL | 2361 | P20929 | |
| LLKAKTLEIEACRGM | 311 | P07196 |